L-Nutra Reports Initial Data Showing Improvements in Metabolic Risk Factors in Patients with Prostate Cancer

LOS ANGELES--(BUSINESS WIRE)--L-Nutra Inc., the world’s leading nutrition technology company pioneering the discovery, design, and commercialization of novel programs and therapeutics that impact both the body’s metabolism and cellular rejuvenation, today announced data from a first-of-its-kind study evaluating the impact of its Fasting Mimicking Technology (FMT) on metabolic risk factors...

Click to view original post